Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 22 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Compass Therapeutics, Inc. | 6,603,336 | reported | 08 Feb 2026 | tx 43+10,178,837−316,037 |
| Relypsa Inc | 0 | reported | 01 Sept 2016 | tx 20+50,040−95,061 |
| Audentes Therapeutics, Inc. | 0 | reported | 15 Jan 2020 | tx 11+44,200−157,586 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Feb 2026 | TAX_WITHHOLDING | Compass Therapeutics, Inc. | 36,687 | 6.52 USD | |
| 09 Jan 2026 | TAX_WITHHOLDING | Compass Therapeutics, Inc. | 46,777 | 5.35 USD | |
| 02 Jan 2026 | GRANT_AWARD | Compass Therapeutics, Inc. | 250,000 | 5.17 USD | |
| 02 Jan 2026 | GRANT_AWARD | Compass Therapeutics, Inc. | 2,000,000 | 0.00 USD | deriv |
| 16 Nov 2025 | TAX_WITHHOLDING | Compass Therapeutics, Inc. | 44,025 | 4.83 USD | |
| 27 May 2025 | PURCHASE | Compass Therapeutics, Inc. | 10,000 | 2.11 USD | first after silence |
| 11 Feb 2025 | GRANT_AWARD | Compass Therapeutics, Inc. | 1,500,000 | 0.00 USD | deriv |
| 08 Feb 2025 | TAX_WITHHOLDING | Compass Therapeutics, Inc. | 41,687 | 3.50 USD | |
| 09 Jan 2025 | TAX_WITHHOLDING | Compass Therapeutics, Inc. | 58,054 | 1.86 USD | |
| 08 Feb 2024 | TAX_WITHHOLDING | Compass Therapeutics, Inc. | 44,782 | 1.45 USD | |
| 09 Jan 2024 | GRANT_AWARD | Compass Therapeutics, Inc. | 637,500 | 1.93 USD | |
| 09 Jan 2024 | GRANT_AWARD | Compass Therapeutics, Inc. | 637,500 | 0.00 USD | deriv |
| 17 Nov 2023 | TAX_WITHHOLDING | Compass Therapeutics, Inc. | 44,025 | 1.50 USD | |
| 10 Mar 2023 | PURCHASE | Compass Therapeutics, Inc. | 10,000 | 3.37 USD | |
| 27 Feb 2023 | PURCHASE | Compass Therapeutics, Inc. | 20,000 | 3.98 USD | |
| 15 Feb 2023 | PURCHASE | Compass Therapeutics, Inc. | 20,000 | 3.86 USD | |
| 08 Feb 2023 | GRANT_AWARD | Compass Therapeutics, Inc. | 500,000 | 0.00 USD | |
| 08 Feb 2023 | GRANT_AWARD | Compass Therapeutics, Inc. | 700,000 | 0.00 USD | deriv |
| 31 Jan 2023 | PURCHASE | Compass Therapeutics, Inc. | 20,000 | 4.05 USD | |
| 24 Jan 2023 | PURCHASE | Compass Therapeutics, Inc. | 20,000 | 4.19 USD | |
| 28 Sept 2022 | PURCHASE | Compass Therapeutics, Inc. | 10,000 | 2.32 USD | |
| 26 Sept 2022 | PURCHASE | Compass Therapeutics, Inc. | 15,000 | 2.27 USD | |
| 07 Sept 2022 | PURCHASE | Compass Therapeutics, Inc. | 15,000 | 3.03 USD | |
| 01 Sept 2022 | PURCHASE | Compass Therapeutics, Inc. | 15,000 | 2.83 USD | |
| 17 Aug 2022 | PURCHASE | Compass Therapeutics, Inc. | 15,000 | 3.05 USD |
3 purchases reported after at least 12 months of silence — most recent on 27 May 2025.